Acute retinal necrosis from the virologist's perspective;Akute retinale Nekrose aus Virologensicht

Ophthalmologe

Volumn 106, Issue 12, 2009, Pages 1065-1073

  Rautenberg, P ^a   Grancicova L ^a   Hillenkamp, J ^a   Nolle B ^a   Roider, J B ^a   Fickenscher, H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Acute retinal necrosis; Antiviral resistance; Antiviral therapy; Molecular and serological diagnostics; Varicella zoster virus

Indexed keywords

ARTICLE; HUMAN; KIRISAWA UVEITIS; VIRAL EYE INFECTION; VIROLOGY;

EYE INFECTIONS, VIRAL; HUMANS; RETINAL NECROSIS SYNDROME, ACUTE;

EID: 75549085222     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-009-2048-4     Document Type: Article

References (98)

1. Urayama A, Yamada N, Sasaki T (1971) Unilateral acute uveitis with periarteritis and detachment. Jpn J Clin Ophthalmol 25:607-619
2. Holland GN, the Executive Committee of the American Uveitis Society (1994) Standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol 117:663-667
3. Muthiah MN, Michaelides M, Child CS, Mitchell SM (2007) Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol 91:1452-1455
4. Vandercam T, Hintzen RQ, de Boer JH, van der Lelij A (2008) Herpetic encephalitis is a risk factor for acute retinal necrosis. Neurology 71:1268-1274
5. Culbertson WW, Atherton SS (1993) Acute retinal necrosis and similar retinitis syndromes. Int Ophthalmol Clin 33:129-143
6. Tajunisah I, Reddy SC, Tan LH (2009) Acute retinal necrosis by cytomegalovirus in an immunocompetent adult: case report and review of the literature. Int Ophthalmol 29:85-90
7. Silverstein BE, Conrad D, Margolis TP, Wong IG (1997) Cytomegalovirus-associated acute retinal necrosis syndrome. Am J Ophthalmol 123:257-258
8. Voros GM, Pandit R, Snow M, Griffiths PG (2006) Unilateral recurrent acute retinal necrosis syndrome caused by cytomegalovirus in an immune-competent adult. Eur J Ophthalmol 16:484-486
9. Abe T, Tsuchida K, Tamai K (1996) A comparative study of the polymerase chain reaction and local antibody production in acute retinal necrosis syndrome and cytomegalovirus retinitis. Graefes Arch Clin Exp Ophthalmol 234:419-424
10. Hillenkamp J, Nölle B, Bruns C et al (2009) Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. Ophthalmology 116:1971-1975
11. Itoh N, Matsumura N, Ogi A et al (2000) High prevalence of herpes simplex virus type 2 in acute retinal necrosis syndrome associated with herpes simplex virus in Japan. Am J Ophthalmol 129:404-405
12. Lau CH, Missotten T, Salzmann J, Lightman SL (2007) Acute retinal necrosis: features, management, and outcomes. Ophthalmology 114:756-762
13. Ongkosuwito JV, Van der Lelij A, Bruinenberg M et al (1998) Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis. Br J Ophthalmol 82:245-251
14. Sugita S, Shimizu N, Watanabe K et al (2008) Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol 93:928-932
15. Tran TH, Rozenberg F, Cassoux N et al (2003) Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis. Br J Ophthalmol 87:79-83
16. Yamamoto S, Sugita S, Sugamoto Y et al (2008) Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Jpn J Ophthalmol 52:463-467
17. Steiner I, Kennedy PG, Pachner AR (2007) The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 6:1015-1028
18. Mott KR, Bresee CJ, Allen SJ et al (2009) Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice. J Virol 835:2246-2254
19. Theil D, Derfuss T, Paripovic I et al (2003) Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 1636:2179-2184
20. Khanna KM, Lepisto AJ, Decman V, Hendricks RL (2004) Immune control of herpes simplex virus during latency. Curr Opin Immunol 64:463-469
21. Knickelbein JE, Khanna KM, Yee MB et al (2008) Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 5899:268-271
22. Malvy D, Ezzedine K, Lançon F et al (2007) Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study. J Eur Acad Dermatol Venereol 21:1398-1403
23. Lorette G, Crochard A, Mimaud V et al (2006) A survey on the prevalence of orofacial herpes in France: the INSTANT Study. J Am Acad Dermatol 55:225-232
24. Liesegang TJ (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20:1-13
25. Lafferty WE, Coombs RW, Benedetti J et al (1987) Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 316:1444-1449
26. Pevenstein SR, Williams RK, McChesney D et al (1999) Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol 73:10514-10518
27. Hüfner K, Horn A, Derfuss T et al (2009) Fewer latent herpes simplex virus type 1 and cytotoxic T cells occur in the ophthalmic division than in the maxillary and mandibular divisions of the human trigeminal ganglion and nerve. J Virol 83:3696-3703
28. Crough T, Khanna R (2009) Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 221:76-98
29. Sinclair J (2008) Human cytomegalovirus: latency and reactivation in the myeloid lineage. J Clin Virol 41:180-185
30. Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763-1779
31. Miyashita EM, Yang B, Lam KM et al (1995) A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593-601
32. Labetoulle M, Kucera P, Ugolini G et al (2000) Neuronal pathways for the propagation of herpes simplex virus type 1 from one retina to the other in a murine model. J Gen Virol 81:1201-1210
33. Goto H, Mochizuki M, Yamaki K et al (2007) Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 51:41-44
34. Malkin JE, Morand P, Malvy D et al (2002) Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex Transm Infect 78:201-203
35. Ganatra JB, Chandler D, Santos C et al (2000) Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol 129:166-172
36. Van Gelder RN, Willig JL, Holland GN, Kaplan HJ (2001) Herpes simplex virus type 2 as a cause of acute retinal necrosis syndrome in young patients. Ophthalmology 108:869-876
37. Kychenthal A, Coombes A, Greenwood J, Pavesio C (2001) Bilateral acute retinal necrosis and herpes simplex type 2 encephalitis in a neonate. Br J Ophthalmol 85:629-630
38. Rahhal FM, Siegel LM, Russak V et al (1996) Clinicopathologic correlations in acute retinal necrosis caused by Herpes simplex Virus type 2. Arch Ophthalmol 114:1416-1419
39. Schlingemann RO, Bruinenberg M, Wertheim-van Dillen P, Feron E (1996) Twenty years' delay of fellow eye involvement in herpes simplex virus type 2-associated bilateral acute retinal necrosis syndrome. Am J Ophthalmol 122:891-892
40. Tran TH, Stanescu D, Caspers-Velu L et al (2003) Clinical characteristics of acute HSV-2 retinal necrosis. Am J Ophthalmol 137:872-879
41. Usui Y, Takeuchi M, Goto H et al (2008) Acute retinal necrosis in Japan. Ophthalmology 115:1632-1633
42. Falcone PM, Brockhurst RJ (1993) Delayed onset of bilateral acute retinal necrosis syndrome: a 34-year interval. Ann Ophthalmol (Skokie) 25:373-374
43. Saari KM, Böke W, Manthey KF et al (1982) Bilateral acute retinal necrosis. Am J Ophthalmol 93:403-411
44. Palay DA, Sternberg P Jr, Davis J et al (1991) Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol 112:250-255
45. Cordero-Coma M, Anzaar F, Yilmaz T, Foster CS (2007) Herpetic retinitis. Herpes 14:4-10
46. Holland GN, Cornell PJ, Park MS et al (1989) An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. Am J Ophthalmol 108:370-374
47. Matsuo T, Matsuo N (1991) HLA-DR9 associated with the severity of acute retinal necrosis syndrome. Ophthalmologica 203:133-137
48. Bristow EA, Cottrell DG, Pandit RJ (2006) Bilateral acute retinal necrosis syndrome following herpes simplex type 1 encephalitis. Eye 20:1327-1330
49. de la Blanchardiere A, Rozenberg F, Caumes E et al (2000) Neurological complications of Varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis 32:263-269
50. Gain P, Chiquet C, Thuret G et al (2002) Herpes simplex virus type 1 encephalitis associated with acute retinal necrosis syndrome in an immunocompetent patient. Acta Ophthalmol Scand 80:546-549
51. Gaynor BD, Wade NK, Cunningham ET (2001) Herpes simplex virus type 1 associated acute retinal necrosis following encephalitis. Retina 21:688-690
52. Hadden PW, Barry CJ (2002) Images in clinical medicine. Herpetic encephalitis and acute retinal necrosis. N Engl J Med 347:1932
53. Kim C, Yoon YH (2002) Unilateral acute retinal necrosis occurring 2 years after herpes simplex type 1 encephalitis. Ophthalmic Surg Lasers 33:250-252
54. Maertzdorf J, Van der Lelij A, Baarsma GS et al (2001) Herpes simplex virus type 1 HSV-1-induced retinitis following herpes simplex encephalitis: indications for brain-to-eye transmission of HSV-1. Ann Neurol 49:104-106
55. Pavesio CE, Conrad DK, McCluskey PJ et al (1997) Delayed acute retinal necrosis after herpetic encephalitis. Br J Ophthalmol 81:415-416
56. Yamamoto S, Nakao T, Kajiyama K (2007) Acute retinal necrosis following herpes simplex encephalitis. Arch Neurol 64:283
57. Winterhalter S, Adams O, Althaus CH et al (2007) Akute Retinanekrose. Klin Monatsbl Augenheilkd 224:567-574
58. de Boer JH, Verhagen C, Bruinenberg M et al (1996) Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol 121:650-658
59. Knox CM, Chandler D, Short GA, Margolis TP (1998) Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis. Use in diagnostic dilemmas. Ophthalmology 105:37-44
60. Hasselbach HC, Fickenscher H, Nölle B, Roider J (2008) Atypical ocular toxoplasmosis with concomitant ocular reactivation of varicella-zoster virus and cytomegalovirus in an immunocompromised host. Klin Monatsbl Augenheilkd 225:236-239
61. Goldmann H, Witmer R (1954) Antikörper im Kammerwassser. Ophthalmologica 127:323-330
62. de Boer JH, Luyendijk L, Rothova A et al (1994) Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am J Ophthalmol 117:201-210
63. Dussaix E, Cerqueti PM, Pontet F, Bloch-Michel E (1987) New approaches to the detection of locally produced antiviral antibodies in the aqueous of patients with endogenous uveitis. Ophthalmologica 194:145-149
64. Fekkar A, Bodaghi B, Touafek F et al (2008) Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 46:1965-1967
65. Kijlstra A, Breebaart AC, Baarsma GS et al (1989) Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol 13:383-386
66. Pepose JS, Flowers B, Stewart JA et al (1992) Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. Am J Ophthalmol 113:248-256
67. Doornenbal P, Seerp Baarsma G, Quint WG et al (1996) Diagnostic assays in cytomegalovirus retinitis: detection of herpesvirus by simultaneous application of the polymerase chain reaction and local antibody analysis on ocular fluid. Br J Ophthalmol 80:235-240
68. Kijlstra A, van den Horn GJ, Luyendijk L et al (1990) Laboratory tests in uveitis. New developments in the analysis of local antibody production. Doc Ophthalmol 75:225-231
69. DeClerq E (2004) Antiviral drugs in current clinical use. J Clin Virol 30:115-133
70. O'Brien JJ, Campoli-Richards DM (1989) Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 37:233-309
71. Blumenkranz MS, Culbertson WW, Clarkson JG, Dix R (1986) Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology 93:296-300
72. Duker S, Blumenkranz MS (1991) Diagnosis and management of the acute retinal necrosis ARN syndrome. Surv Ophthalmol 35:327-343
73. Morse LS, Mizoguchi M (1995) Diagnosis and management of viral retinitis in the acute retinal necrosis syndrome. Semin Ophthalmol 10:28-41
74. Katragadda S, Talluri RS, Pal D, Mitra AK (2005) Identification and characterization of a Na+-dependent neutral amino acid transporter, ASCT1, in rabbit corneal epithelial cell culture and rabbit cornea. Curr Eye Res 30:989-1002
75. Granero GE, Amidon GL (2006) Stability of valacyclovir: implications for its oral bioavailability. Int J Pharm 317:14-18
76. Soul-Lawton J, Seaber E, On N et al (1995) Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 39:2759-2764
77. Huynh TH, Johnson MW, Comer GM, Fish DN (2008) Vitreous penetration of orally administered valacyclovir. Am J Ophthalmol 145:682-686
78. Chakrabarty A, Tyring SK, Beutner K, Rauser M (2004) Recent clinical experience with famciclovir-a "third generation" nucleoside prodrug. Antivir Chem Chemother 15:251-253
79. Fletcher C, Bean B (1985) Evaluation of oral acyclovir therapy. Drug Intell Clin Pharm 19:518-524
80. Chong DY, Johnson MW, Huynh TH et al (2009) Vitreous penetration of orally administered famciclovir. Am J Ophthalmol 148:38-42
81. Figueroa MS, Garabito I, Gutierrez C, Fortun J (1997) Famciclovir for the treatment of acute retinal necrosis ARN syndrome. Am J Ophthalmol 123:255-257
82. Emerson GG, Smith JR, Wilson DJ et al (2006) Primary treatment of acute retinal necrosis with oral antiviral therapy. Ophthalmology 113:2259-2261
83. Savant V, Saeed T, Denniston A, Murray PI (2004) Oral valganciclovir treatment of varicella zoster virus acute retinal necrosis. Eye 18:544-545
84. Aizman A, Johnson MW, Elner SG (2007) Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology 114:307-312
85. DeClerq E, Holy A (2005) Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov 4:928-940
86. Ho ES, Lin DC, Mendel DB, Cihlar T (2000) Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11:383-393
87. Biron KK (2006) Antiviral drugs for cytomegalovirus diseases. Antiviral Res 71:154-163
88. Phan DD, Chin-Hong P, Lin ET et al (2003) Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrob Agents Chemother 47:2351-2353
89. Reid R, Mar EC, Huang ES, Topal MD (1988) Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-1,3-dihydroxy-2-propoxymethylguanine triphosphate. J Biol Chem 2633:898-904
90. Cvetkovic RS, Wellington K (2005) Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs 65:859-878
91. Paya C, Humar A, Dominguez E et al (2004) Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 4:611-620
92. Chou S (2008) Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 18:233-246
93. Zambarakji HH, Obi AA, Mitchell SM (2002) Successful treatment of Varizella-zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy. Ocul Immunol Inflamm 10:41-46
94. Scott IU, Luu KM, Davis JL (2002) Intravitreal antivirals in the management of patients with Aquired Immunodeficiency Syndrome with progressive outer retinal necrosis. Arch Ophthalmol 120:1219-1222
95. Velez G, Roy CE, Whitcup SM et al (2001) High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis. Am J Ophthalmol 131:396-397
96. Balansard B, Bodaghi B, Cassoux N et al (2005) Necrotising retinopathies simulating acute retinal necrosis syndrome. Br J Ophthalmol 89:96-101
97. Moshfeghi DM, Dodds EM, Couto CA et al (2004) Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 111:716-725
98. Forster DJ, Dugel PU, Frangieh GT et al (1990) Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol 110:341-348